Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
2,528 rows where has_cryoEM = 0, has_known_aptamer = 0 and in_cev_map = 0 sorted by priority_score descending
This data as json, CSV (advanced)
in_cev_map 1
- - · 2,528 ✖
has_known_aptamer 1
- - · 2,528 ✖
has_cryoEM 1
- - · 2,528 ✖
has_activation_state_pdb_pair 1
- 0 2,528
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q9Y2C5 | SLC17A4 | Probable small intestine urate exporter | Tier 1.5 | 0.878 | 0 | 83.69 | 0 | 0 | 0 | 0 | 0 | inflammatory bowel disease | 0.09896486250497885 | ||||
| Q9UJA9 | ENPP5 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 | Tier 1 | 0.87 | 1 | 88.12 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.33211724272317855 | ||||
| Q31135 | H2-Ab1 | Tier 1 | 0.83 | 12 | 85.12 | 0 | 0 | 0 | 0 | 0 | |||||||
| P0DPK4 | NOTCH2NLC | Notch homolog 2 N-terminal-like protein C | Tier 1.5 | 0.805 | 0 | 80.81 | 0 | 0 | 0 | 0 | 0 | neuronal intranuclear inclusion disease | 0.4999829066911242 | ||||
| Q14031 | COL4A6 | Collagen alpha-6(IV) chain | Tier 1.5 | 0.79 | 0 | 47.41 | 0 | 0 | 0 | 0 | 0 | Dupuytren Contracture | 0.5880367459451578 | ||||
| P37023 | ACVRL1 | Activin receptor type-1-like | Tier 1.5 | 0.779 | 7 | 82.0 | 0 | 0 | 0 | 0 | 0 | telangiectasia, hereditary hemorrhagic, type 2 | 0.7951167515831324 | ||||
| P01568 | IFNA21 | Interferon alpha-21 | Tier 1.5 | 0.777 | 0 | 85.0 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.3695798546847018 | ||||
| A6ND01 | IZUMO1R | Sperm-egg fusion protein Juno | Tier 1 | 0.773 | 7 | 87.38 | 0 | 0 | 0 | 0 | 0 | placental retention | 0.23306495563589497 | ||||
| A0A5H2UYS3 | HLA-A | Tier 1 | 0.77 | 20 | 85.25 | 0 | 0 | 0 | 0 | 0 | |||||||
| P29017 | CD1C | T-cell surface glycoprotein CD1c | Tier 1.5 | 0.77 | 10 | 88.56 | 0 | 0 | 0 | 0 | 0 | neoplasm | 0.1106047389635713 | ||||
| Q9BVX2 | TMEM106C | Transmembrane protein 106C | Tier 1.5 | 0.77 | 0 | 80.81 | 0 | 0 | 0 | 0 | 0 | prostate carcinoma | 0.21737104399686757 | ||||
| A0A1B0GTW7 | CIROP | Ciliated left-right organizer metallopeptidase | Tier 1.5 | 0.764 | 0 | 73.44 | 0 | 0 | 0 | 0 | 0 | heterotaxy, visceral, 12, autosomal | 0.6929422132808513 | ||||
| O15370 | SOX12 | Transcription factor SOX-12 | Tier 1.5 | 0.76 | 0 | 63.0 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.3277369133971199 | ||||
| Q9BWF2 | TRAIP | E3 ubiquitin-protein ligase TRAIP | Tier 1.5 | 0.76 | 1 | 74.94 | 0 | 0 | 0 | 0 | 0 | Seckel syndrome 9 | 0.683878095944948 | ||||
| Q9BZR8 | BCL2L14 | Apoptosis facilitator Bcl-2-like protein 14 | Tier 1.5 | 0.76 | 0 | 62.38 | 0 | 0 | 0 | 0 | 0 | hypothyroidism | 0.33117514363294837 | ||||
| A6NI61 | MYMK | Protein myomaker | Tier 1.5 | 0.758 | 0 | 90.44 | 0 | 0 | 0 | 0 | 0 | Carey-Fineman-Ziter syndrome | 0.7790386256350393 | ||||
| Q16585 | SGCB | Beta-sarcoglycan | Tier 1.5 | 0.75 | 0 | 76.44 | 0 | 0 | 0 | 0 | 0 | autosomal recessive limb-girdle muscular dystrophy type 2E | 0.8154766151472349 | ||||
| P16471 | PRLR | Prolactin receptor | Tier 1 | 0.747 | 12 | 61.03 | 0 | 0 | 0 | 0 | 0 | familial hyperprolactinemia | 0.5718636087471152 | ||||
| P56730 | PRSS12 | Neurotrypsin | Tier 1.5 | 0.746 | 0 | 77.31 | 0 | 0 | 0 | 0 | 0 | intellectual disability, autosomal recessive 1 | 0.6621935416695687 | ||||
| P01563 | Tier 1 | 0.744 | 13 | 85.06 | 0 | 0 | 0 | 0 | 0 | renal cell carcinoma | 0.3938654263610389 | ||||||
| P16112 | ACAN | Aggrecan core protein | Tier 1.5 | 0.74 | 4 | 51.91 | 0 | 0 | 0 | 0 | 0 | Familial osteochondritis dissecans | 0.7558487616449627 | ||||
| Q14246 | ADGRE1 | Adhesion G protein-coupled receptor E1 | Tier 1.5 | 0.74 | 0 | 76.69 | 0 | 0 | 0 | 0 | 0 | diabetic ketoacidosis | 0.20424823130055986 | ||||
| Q8N6D2 | RNF182 | E3 ubiquitin-protein ligase RNF182 | Tier 1.5 | 0.74 | 0 | 70.25 | 0 | 0 | 0 | 0 | 0 | periapical tissue disease | 0.304701328693288 | ||||
| Q00LT1 | PRCD | Photoreceptor disk component PRCD | Tier 1.5 | 0.737 | 0 | 63.97 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.7650522818524582 | ||||
| Q9Y4U1 | MMACHC | Cyanocobalamin reductase / alkylcobalamin dealkylase | Tier 1.5 | 0.735 | 7 | 85.62 | 0 | 0 | 0 | 0 | 0 | Methylmalonic acidemia with homocystinuria, type cblC | 0.8478185420804271 | ||||
| Q9ULX7 | CA14 | Carbonic anhydrase 14 | Tier 1.5 | 0.734 | 2 | 90.69 | 0 | 0 | 0 | 0 | 0 | epilepsy | 0.4397024990575866 | ||||
| Q99593 | TBX5 | T-box transcription factor TBX5 | Tier 1.5 | 0.733 | 4 | 62.66 | 0 | 0 | 0 | 0 | 0 | Holt-Oram syndrome | 0.827317913681364 | ||||
| P53539 | FOSB | Protein FosB | Tier 1.5 | 0.73 | 12 | 59.12 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.22246010664492422 | ||||
| O43914 | TYROBP | TYRO protein tyrosine kinase-binding protein | Tier 1.5 | 0.728 | 5 | 64.62 | 0 | 0 | 0 | 0 | 0 | Nasu-Hakola disease | 0.7323368313860329 | ||||
| Q16878 | CDO1 | Cysteine dioxygenase type 1 | Tier 1 | 0.72 | 17 | 93.62 | 0 | 0 | 0 | 0 | 0 | adolescent idiopathic scoliosis | 0.3105991982786747 | ||||
| Q9NWH7 | SPATA6 | Spermatogenesis-associated protein 6 | Tier 1.5 | 0.72 | 0 | 65.19 | 0 | 0 | 0 | 0 | 0 | hypothyroidism | 0.4205896274474635 | ||||
| Q15399 | TLR1 | Toll-like receptor 1 | Tier 1.5 | 0.72 | 6 | 87.19 | 0 | 0 | 0 | 0 | 0 | asthma | 0.5956884825296496 | ||||
| Q6MZM0 | HEPHL1 | Ferroxidase HEPHL1 | Tier 1.5 | 0.72 | 0 | 89.44 | 0 | 0 | 0 | 0 | 0 | pili torti-developmental delay-neurological abnormalities syndrome | 0.40268634456935765 | ||||
| Q12918 | KLRB1 | Killer cell lectin-like receptor subfamily B member 1 | Tier 1 | 0.719 | 3 | 81.0 | 0 | 0 | 0 | 0 | 0 | sensory perception of smell | 0.287724180593876 | ||||
| P25100 | ADRA1D | Alpha-1D adrenergic receptor | Tier 1.5 | 0.716 | 0 | 64.81 | 0 | 0 | 0 | 0 | 0 | hypertension | 0.6613200073424285 | ||||
| O60882 | Tier 1.5 | 0.713 | 1 | 83.31 | 0 | 0 | 0 | 0 | 0 | Hypomaturation amelogenesis imperfecta | 0.7281006394540224 | ||||||
| Q99574 | SERPINI1 | Neuroserpin | Tier 1 | 0.712 | 3 | 88.12 | 0 | 0 | 0 | 0 | 0 | familial encephalopathy with neuroserpin inclusion bodies | 0.7162803151916303 | ||||
| A0A583ZB34 | Tier 1 | 0.71 | 9 | 84.38 | 0 | 0 | 0 | 0 | 0 | ||||||||
| P30968 | GNRHR | Gonadotropin-releasing hormone receptor | Tier 1.5 | 0.71 | 1 | 84.19 | 0 | 0 | 0 | 0 | 0 | hypogonadotropic hypogonadism | 0.83100005285263 | ||||
| Q8N9I5 | FADS6 | Fatty acid desaturase 6 | Tier 1.5 | 0.71 | 0 | 90.62 | 0 | 0 | 0 | 0 | 0 | ||||||
| Q9H2B4 | SLC26A1 | Sulfate anion transporter 1 | Tier 1.5 | 0.707 | 0 | 82.62 | 0 | 0 | 0 | 0 | 0 | nephrolithiasis susceptibility caused by SLC26A1 | 0.6690419713525324 | ||||
| P14555 | PLA2G2A | Phospholipase A2, membrane associated | Tier 1 | 0.7 | 17 | 91.0 | 0 | 0 | 0 | 0 | 0 | familial colorectal cancer | 0.3326218692162316 | ||||
| Q5Y7D3 | HLA-DQB1 | Tier 1 | 0.7 | 6 | 85.31 | 0 | 0 | 0 | 0 | 0 | |||||||
| O95886 | DLGAP3 | Disks large-associated protein 3 | Tier 1.5 | 0.7 | 0 | 50.16 | 0 | 0 | 0 | 0 | 0 | benign neoplasm of adrenal gland | 0.3188339358953556 | ||||
| Q96LB9 | PGLYRP3 | Peptidoglycan recognition protein 3 | Tier 1.5 | 0.699 | 4 | 88.12 | 0 | 0 | 0 | 0 | 0 | Romano-Ward syndrome | 0.08833005834552343 | ||||
| Q01814 | ATP2B2 | Plasma membrane calcium-transporting ATPase 2 | Tier 1.5 | 0.696 | 0 | 73.38 | 0 | 0 | 0 | 0 | 0 | autosomal dominant nonsyndromic hearing loss | 0.6637167639130592 | ||||
| O43570 | CA12 | Carbonic anhydrase 12 | Tier 1 | 0.695 | 40 | 87.81 | 0 | 0 | 0 | 0 | 0 | isolated hyperchlorhidrosis | 0.6794515382695604 | ||||
| O00337 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Tier 1.5 | 0.695 | 0 | 82.25 | 0 | 0 | 0 | 0 | 0 | uridine-cytidineuria | 0.5835072752618243 | ||||
| P28039 | AOAH | Acyloxyacyl hydrolase | Tier 1.5 | 0.695 | 2 | 90.38 | 0 | 0 | 0 | 0 | 0 | type 2 diabetes mellitus | 0.4486206035972812 | ||||
| P49895 | DIO1 | Type I iodothyronine deiodinase | Tier 1.5 | 0.695 | 0 | 92.12 | 0 | 0 | 0 | 0 | 0 | thyroid hormone metabolism, abnormal, 2 | 0.6505024812924749 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;